EcoDrugPlus

Alpha-2c Adrenergic Receptor-Like

Ensembl ID : ENSAMXG00000026504
Gene Symbol: LOC103033245
3 Cross references
162 Possible Orthologues:

Alpha-Synuclein-Like

Ensembl ID : ENSAMXG00000038674
Gene Symbol: LOC103026281
2 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSAMXG00000012011
Gene Symbol: AOC1
3 Cross references
233 Possible Orthologues:

Amylase Alpha 1a

Ensembl ID : ENSAMXG00000031737
Gene Symbol: AMY1A
4 Cross references
207 Possible Orthologues:

Amyloid Beta A4 Protein-Like

Ensembl ID : ENSAMXG00000002725
Gene Symbol: LOC103046668
3 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSAMXG00000015133
Gene Symbol: APP
2 Cross references
205 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSAMXG00000011395
Gene Symbol: AR
3 Cross references
213 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSAMXG00000025929
Gene Symbol: AGTR1
3 Cross references
149 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSAMXG00000025004
Gene Symbol: AGTR1
3 Cross references
203 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSAMXG00000026470
Gene Symbol: AGTR2
4 Cross references
171 Possible Orthologues:

Anti-Apoptotic Protein Nr13-Like

Ensembl ID : ENSAMXG00000016292
Gene Symbol: LOC103035823
3 Cross references
129 Possible Orthologues:

Apelin Receptor A-Like

Ensembl ID : ENSAMXG00000043579
Gene Symbol: LOC103029160
3 Cross references
172 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).